Unnamed: 0,title,date,stock,sentiment
182876.0,Bio-Path Holdings Highlights Presentations At 2020 ASCO Annual Meeting,2020-05-29 08:28:00-04:00,BPTH,neutral
182877.0,61 Biggest Movers From Yesterday,2020-05-20 04:50:00-04:00,BPTH,neutral
182878.0,44 Stocks Moving In Tuesday's Mid-Day Session,2020-05-19 12:48:00-04:00,BPTH,neutral
182879.0,Bio-Path shares are trading higher after HC Wainwright & Co maintained its Buy rating on the stock.,2020-05-18 09:00:00-04:00,BPTH,positive
182880.0,"HC Wainwright & Co. Reiterates Buy on Bio-Path Holdings, Lowers Price Target to $18",2020-05-18 07:28:00-04:00,BPTH,negative
182881.0,"The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO",2020-05-15 07:49:00-04:00,BPTH,negative
182882.0,Bio-Path Holdings Q1 EPS $(0.900) Misses $(0.670) Estimate,2020-05-15 07:05:00-04:00,BPTH,negative
182883.0,"Earnings Scheduled For May 15, 2020",2020-05-15 05:06:00-04:00,BPTH,neutral
182884.0,Bio-Path Highlights Upcoming Presentation On DNAbilize At ASCO May 29,2020-05-13 17:20:00-04:00,BPTH,neutral
182885.0,90 Biggest Movers From Friday,2020-03-30 05:10:00-04:00,BPTH,neutral
182886.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,BPTH,positive
182887.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,BPTH,negative
182888.0,"The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study",2020-03-06 08:49:00-05:00,BPTH,negative
182889.0,24 Stocks Moving in Friday's Pre-Market Session,2020-03-06 07:20:00-05:00,BPTH,neutral
182890.0,Bio-Path Holdings Q4 EPS $(0.7) Down From $(0.16) YoY,2020-03-06 07:04:00-05:00,BPTH,neutral
182891.0,"Earnings Scheduled For March 6, 2020",2020-03-06 04:35:00-05:00,BPTH,neutral
182892.0,85 Biggest Movers From Yesterday,2020-03-04 05:04:00-05:00,BPTH,neutral
182893.0,35 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-02-18 08:25:00-05:00,BPTH,neutral
182894.0,50 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-01-08 08:31:00-05:00,BPTH,neutral
182895.0,Bio-Path Provides Clinical Update And 2020 Outlook,2020-01-08 08:10:00-05:00,BPTH,neutral
182896.0,72 Biggest Movers From Yesterday,2019-12-05 05:10:00-05:00,BPTH,neutral
182897.0,"H.C. Wainwright Reiterates Buy on Bio-Path Holdings, Lowers Price Target to $25",2019-12-02 07:22:00-05:00,BPTH,negative
182898.0,Bio-Path Reports Successful Completion Of Safety Testing In Stage 2 Of Phase 2 Trial In Acute Myeloid Leukemia,2019-11-26 08:08:00-05:00,BPTH,positive
182899.0,66 Biggest Movers From Yesterday,2019-11-22 04:50:00-05:00,BPTH,neutral
182900.0,45 Stocks Moving In Thursday's Mid-Day Session,2019-11-21 12:11:00-05:00,BPTH,neutral
182901.0,Bio-Path Holdings Announces $8M Registered Direct Offering Priced At-The-Market,2019-11-21 11:31:00-05:00,BPTH,neutral
182902.0,Bio-Path Holdings Shares Halted On Circuit Breaker,2019-11-21 11:31:00-05:00,BPTH,positive
182903.0,Bio-Path Reports Clearance Of Investigational New Drug Application For BP1002,2019-11-21 08:07:00-05:00,BPTH,neutral
182904.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,BPTH,negative
182905.0,Bio-Path Holdings Q3 EPS $(0.78) Misses $(0.74) Estimate,2019-11-15 07:01:00-05:00,BPTH,negative
182906.0,"Earnings Scheduled For November 15, 2019",2019-11-15 05:09:00-05:00,BPTH,neutral
182907.0,64 Biggest Movers From Yesterday,2019-10-15 05:07:00-04:00,BPTH,neutral
182908.0,50 Biggest Movers From Yesterday,2019-09-27 04:31:00-04:00,BPTH,neutral
182909.0,23 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-25 08:17:00-04:00,BPTH,neutral
182910.0,Bio-Path Announces Issuance Of US Patent For DNAbilize,2019-09-25 08:03:00-04:00,BPTH,neutral
182911.0,Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia,2019-08-26 07:05:00-04:00,BPTH,neutral
182912.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,BPTH,neutral
182913.0,Bio-Path Holdings Q2 EPS $(0.87) Down From $(0.15) YoY,2019-08-15 07:10:00-04:00,BPTH,neutral
182914.0,60 Biggest Movers From Yesterday,2019-07-18 05:03:00-04:00,BPTH,neutral
182915.0,44 Stocks Moving In Wednesday's Mid-Day Session,2019-07-17 12:10:00-04:00,BPTH,neutral
182916.0,"A Look At Benzinga Pro's Most-Searched Tickers For July 17, 2019",2019-07-17 11:39:00-04:00,BPTH,neutral
182917.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wednesday, July 17, 2019",2019-07-17 09:57:00-04:00,BPTH,positive
182918.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-07-17 08:19:00-04:00,BPTH,neutral
182919.0,58 Biggest Movers From Yesterday,2019-07-17 04:59:00-04:00,BPTH,neutral
182920.0,41 Stocks Moving In Tuesday's Mid-Day Session,2019-07-16 12:10:00-04:00,BPTH,neutral
182921.0,Bio-Path Holdings shares are trading higher after H.C. Wainwright initiated coverage on the company's stock with a Buy rating and a $28 price target.,2019-07-16 09:51:00-04:00,BPTH,positive
182922.0,"Benzinga's Top Upgrades, Downgrades For July 16, 2019",2019-07-16 09:05:00-04:00,BPTH,positive
182923.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-07-16 08:14:00-04:00,BPTH,neutral
182924.0,"H.C. Wainwright Initiates Coverage On Bio-Path Holdings with Buy Rating, Announces $28 Price Target",2019-07-16 07:27:00-04:00,BPTH,neutral
182925.0,44 Biggest Movers From Yesterday,2019-07-03 05:24:00-04:00,BPTH,neutral
182926.0,Mid-Day Market Update: Crude Oil Down 3.5%; MDJM Shares Spike Higher,2019-07-02 12:47:00-04:00,BPTH,negative
182927.0,33 Stocks Moving In Tuesday's Mid-Day Session,2019-07-02 12:11:00-04:00,BPTH,neutral
182928.0,Mid-Morning Market Update: Markets Edge Lower; Greenbrier Misses Q3 Expectations,2019-07-02 10:09:00-04:00,BPTH,negative
182929.0,"Bio-Path shares are trading higher after patent site USPTO showed the company received a patent entitled ""P-ethoxy nucleic acids for liposomal formulation.""",2019-07-02 09:57:00-04:00,BPTH,positive
182930.0,Bio-Path Holdings Shares Resume Trade,2019-07-02 09:56:00-04:00,BPTH,positive
182931.0,Bio-Path Holdings Shares Halted On Circuit Breaker,2019-07-02 09:51:00-04:00,BPTH,positive
182932.0,USPTO Site  Bio-Path Has Received Patent Entitled 'P-ethoxy nucleic acids for liposomal formulation',2019-07-02 09:51:00-04:00,BPTH,positive
182933.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-06-12 08:20:00-04:00,BPTH,neutral
182934.0,66 Biggest Movers From Yesterday,2019-06-12 04:44:00-04:00,BPTH,neutral
182935.0,Bio-Path shares are trading lower after the company's S-3 showed registration for a $125 million mixed securities offering; the company also issued Q1 EPS down from last year.,2019-05-16 16:27:00-04:00,BPTH,positive
182936.0,Bio-Path S-3 Shows Registration For $125M Mixed Securities Offering,2019-05-16 16:22:00-04:00,BPTH,positive
182937.0,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",2019-05-16 07:40:00-04:00,BPTH,neutral
182938.0,"Bio-Path Holdings, Inc. - Common Stock Q1 EPS $(0.89) Down From $(0.17) YoY",2019-05-16 07:11:00-04:00,BPTH,neutral
182939.0,58 Biggest Movers From Yesterday,2019-05-15 05:09:00-04:00,BPTH,neutral
182940.0,54 Biggest Movers From Thursday,2019-04-22 05:25:00-04:00,BPTH,neutral
182941.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-04-18 12:48:00-04:00,BPTH,neutral
182942.0,31 Stocks Moving In Thursday's Pre-Market Session,2019-04-18 08:40:00-04:00,BPTH,neutral
182943.0,Bio-Path Shares Spike Higher On Volume As Traders Circulate 'Solid Tumor Cancer Cures: Bio-Path Holdings May Hold the Key',2019-04-16 14:21:00-04:00,BPTH,negative
182944.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tue., Apr. 16, 2019",2019-04-16 10:36:00-04:00,BPTH,positive
182945.0,21 Stocks Moving In Tuesday's Pre-Market Session,2019-04-16 08:06:00-04:00,BPTH,neutral
182946.0,44 Biggest Movers From Yesterday,2019-04-16 05:44:00-04:00,BPTH,neutral
182947.0,34 Stocks Moving In Monday's Mid-Day Session,2019-04-15 12:16:00-04:00,BPTH,neutral
182948.0,Mid-Day Market Update: Electronics for Imaging Surges Following Acquisition News; Reebonz Shares Plummet,2019-04-15 12:09:00-04:00,BPTH,positive
182949.0,Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Posts Mixed Q1 Results,2019-04-15 10:24:00-04:00,BPTH,negative
182950.0,30 Stocks Moving In Monday's Pre-Market Session,2019-04-15 09:01:00-04:00,BPTH,neutral
182951.0,"Bio-Path shares are trading higher after the company withdrew its S-1 registration form, indicating it will not dilute shares.",2019-04-15 08:21:00-04:00,BPTH,positive
182952.0,Bio-Path Holdings Shares Soar 66% Premarket After Co Withdraws Offering,2019-04-15 04:18:00-04:00,BPTH,positive
182953.0,50 Biggest Movers From Yesterday,2019-04-09 06:48:00-04:00,BPTH,neutral
182954.0,Bio-Path Presented Preclinical Data For BP1003 At AACR Meeting,2019-04-03 08:04:00-04:00,BPTH,neutral
182955.0,62 Biggest Movers From Friday,2019-04-01 04:46:00-04:00,BPTH,neutral
182956.0,31 Stocks Moving In Wednesday's Pre-Market Session,2019-03-27 08:39:00-04:00,BPTH,neutral
182957.0,52 Biggest Movers From Yesterday,2019-03-26 05:04:00-04:00,BPTH,neutral
182958.0,41 Stocks Moving In Monday's Mid-Day Session,2019-03-25 12:51:00-04:00,BPTH,neutral
182959.0,30 Stocks Moving In Monday's Pre-Market Session,2019-03-25 08:11:00-04:00,BPTH,neutral
182960.0,60 Biggest Movers From Friday,2019-03-25 05:42:00-04:00,BPTH,neutral
182961.0,"What A $30,000 Losing Trade Looks Like, And How To Bounce Back",2019-03-22 15:54:00-04:00,BPTH,neutral
182962.0,Mid-Afternoon Market Update: Dow Down Over 300 Points; JinkoSolar Shares Fall After Q4 Results,2019-03-22 14:47:00-04:00,BPTH,positive
182963.0,41 Stocks Moving In Friday's Mid-Day Session,2019-03-22 12:30:00-04:00,BPTH,neutral
182964.0,Mid-Day Market Update: Crude Oil Down 2%; Immutep Shares Spike Higher,2019-03-22 12:12:00-04:00,BPTH,negative
182965.0,"Bio-Path shares are trading higher, continuing its path of volatility, after the company's stock spiked from $2 to $73 and back to the $20 range all within the past month.",2019-03-22 10:44:00-04:00,BPTH,positive
182966.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Fri., Mar. 22, 2019",2019-03-22 09:23:00-04:00,BPTH,positive
182967.0,30 Stocks Moving In Friday's Pre-Market Session,2019-03-22 08:02:00-04:00,BPTH,neutral
182968.0,60 Biggest Movers From Yesterday,2019-03-22 05:36:00-04:00,BPTH,neutral
182969.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-03-21 12:56:00-04:00,BPTH,neutral
182970.0,"Bio-Path Holdings shares are continuing lower on no apparent news. Shares of Bio-Path fell 24% in the previous 5 sessions, but are up 843% over the past month.",2019-03-21 09:00:00-04:00,BPTH,neutral
182971.0,31 Stocks Moving In Thursday's Pre-Market Session,2019-03-21 07:50:00-04:00,BPTH,neutral
182972.0,52 Biggest Movers From Yesterday,2019-03-21 04:59:00-04:00,BPTH,neutral
182973.0,Mid-Afternoon Market Update: Fed Expects No Interest Rate Hikes In 2019; Dow Down Over 100 Points,2019-03-20 15:36:00-04:00,BPTH,positive
182974.0,41 Stocks Moving In Wednesday's Mid-Day Session,2019-03-20 12:00:00-04:00,BPTH,neutral
182975.0,Bio-Path Holdings Shares Down Modestly Following Earlier Results: Q4 EPS $(0.16) Up From $(0.74) YoY,2019-03-20 08:42:00-04:00,BPTH,positive
182976.0,70 Biggest Movers From Yesterday,2019-03-20 05:36:00-04:00,BPTH,neutral
182977.0,"Earnings Scheduled For March 20, 2019",2019-03-20 04:49:00-04:00,BPTH,neutral
182978.0,45 Stocks Moving In Tuesday's Mid-Day Session,2019-03-19 13:21:00-04:00,BPTH,neutral
182979.0,45 Stocks Moving In Tuesday's Mid-Day Session,2019-03-19 13:10:00-04:00,BPTH,neutral
182980.0,71 Biggest Movers From Yesterday,2019-03-15 05:24:00-04:00,BPTH,neutral
182981.0,Bio-Path 13G Filing From Sabby Mgmt. Shows New 9.48% Stake,2019-03-14 11:39:00-04:00,BPTH,neutral
182982.0,68 Biggest Movers From Yesterday,2019-03-14 05:22:00-04:00,BPTH,neutral
182983.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Wed., Mar. 13, 2019",2019-03-13 08:52:00-04:00,BPTH,positive
182984.0,40 Stocks Moving In Wednesday's Pre-Market Session,2019-03-13 08:10:00-04:00,BPTH,neutral
182985.0,56 Biggest Movers From Yesterday,2019-03-13 06:04:00-04:00,BPTH,neutral
182986.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-03-12 14:06:00-04:00,BPTH,neutral
182987.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Tues., Mar. 12, 2019",2019-03-12 13:35:00-04:00,BPTH,positive
182988.0,UPDATE: Bio-Path Prices ~713K Shares At $25.95/Share,2019-03-12 09:17:00-04:00,BPTH,positive
182989.0,Bio-Path Reports $18.5M Direct Offering Of Common Stock,2019-03-12 09:16:00-04:00,BPTH,neutral
182990.0,25 Stocks Moving In Tuesday's Pre-Market Session,2019-03-12 08:02:00-04:00,BPTH,neutral
182991.0,50 Biggest Movers From Yesterday,2019-03-12 05:04:00-04:00,BPTH,neutral
182992.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Mar. 11, 2019",2019-03-11 15:36:00-04:00,BPTH,positive
182993.0,40 Stocks Moving In Monday's Mid-Day Session,2019-03-11 12:02:00-04:00,BPTH,neutral
182994.0,70 Biggest Movers From Friday,2019-03-11 05:26:00-04:00,BPTH,neutral
182995.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,BPTH,neutral
182996.0,The Secret To Trading Stocks Like Bio-Path That Helped Me Quit My Desk Job And Make Thousands,2019-03-08 13:25:00-05:00,BPTH,positive
182997.0,50 Stocks Moving In Friday's Mid-Day Session,2019-03-08 12:31:00-05:00,BPTH,neutral
182998.0,What's Behind TrovaGene's Volatile Ride?,2019-03-08 12:28:00-05:00,BPTH,neutral
182999.0,28 Stocks Moving In Friday's Pre-Market Session,2019-03-08 07:54:00-05:00,BPTH,neutral
183000.0,"'Taking the measure of small-cap biotech: Bio-Path Holdings, CytoDyn' -STAT News' Adam Feuerstein",2019-03-08 07:48:00-05:00,BPTH,neutral
183001.0,"Benzinga Pro Top 10 Most-Searched Tickers For Morning Of Fri., Mar. 8, 2019",2019-03-08 07:34:00-05:00,BPTH,positive
183002.0,64 Biggest Movers From Yesterday,2019-03-08 05:22:00-05:00,BPTH,neutral
183003.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Thurs., Mar. 7, 2019",2019-03-07 15:36:00-05:00,BPTH,positive
183004.0,Mid-Afternoon Market Update: Resideo Technologies Drops After Q4 Earnings; Seelos Therapeutics Shares Climb,2019-03-07 14:29:00-05:00,BPTH,positive
183005.0,Bio-Path Jumps Nearly 600% In 2 Days: What You Need To Know,2019-03-07 14:05:00-05:00,BPTH,neutral
183006.0,51 Stocks Moving In Thursday's Mid-Day Session,2019-03-07 12:32:00-05:00,BPTH,neutral
183007.0,Mid-Day Market Update: Titan International Falls Following Downbeat Q4 Results; GTx Shares Jump,2019-03-07 12:10:00-05:00,BPTH,positive
183008.0,"Bio-Path Shares Resume Trade, Up 401%",2019-03-07 11:20:00-05:00,BPTH,positive
183009.0,"Bio-Path Shares Halted On Sixth Circuit Breaker, Up 440%",2019-03-07 11:15:00-05:00,BPTH,positive
183010.0,"Bio-Path Shares Resume Trade, Continue Higher, Now Over $60, Up 403%",2019-03-07 11:14:00-05:00,BPTH,positive
183011.0,"Bio-Path Shares Halted On Fifth Circuit Breaker, Up 353%",2019-03-07 11:09:00-05:00,BPTH,positive
183012.0,"Bio-Path Shares Resume Trade, Continue Higher; Stock Now Up 350% At $54",2019-03-07 11:08:00-05:00,BPTH,positive
183013.0,"Bio-Path Shares Halted On Circuit Breaker; Stock Has Been Halted Multiple Times, Turn On Signals To Be Alerted To All Halts And Resumptions",2019-03-07 11:03:00-05:00,BPTH,positive
183014.0,Bio-Path Holdings Shares Resume Trade,2019-03-07 11:00:00-05:00,BPTH,positive
183015.0,"Bio-Path Shares Halted On Another Circuit Breaker, Up 242% Over $41",2019-03-07 10:54:00-05:00,BPTH,positive
183016.0,Mid-Morning Market Update: Markets Open Lower; Kroger Misses Q4 Expectations,2019-03-07 10:07:00-05:00,BPTH,negative
183017.0,"Bio-Path Shares Halted On Circuit Breaker To Downside, Shares Up 105% For Session At $24.58",2019-03-07 09:49:00-05:00,BPTH,positive
183018.0,"Bio-Path Shares Now Over $28 Level, Up 130+%",2019-03-07 09:42:00-05:00,BPTH,positive
183019.0,"Bio-Path Shares Pullback From Session High, Up 91% For Session",2019-03-07 09:41:00-05:00,BPTH,positive
183020.0,Bio-Path Shares Resume Trade,2019-03-07 09:39:00-05:00,BPTH,positive
183021.0,Bio-Path Holdings Shares Halted On Circuit Breaker,2019-03-07 09:35:00-05:00,BPTH,positive
183022.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Thurs., Mar. 7, 2019",2019-03-07 09:00:00-05:00,BPTH,positive
183023.0,Bio-Path shares are trading higher on continued strength after the company on Wednesday announced BP1001 for the treatment of acute myeloid leukemia demonstrated 'meaningful clinical improvement' with an 'excellent' patient safety profile.,2019-03-07 08:24:00-05:00,BPTH,positive
183024.0,26 Stocks Moving In Thursday's Pre-Market Session,2019-03-07 08:01:00-05:00,BPTH,neutral
183025.0,58 Biggest Movers From Yesterday,2019-03-07 04:55:00-05:00,BPTH,neutral
183026.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Wed., Mar. 6, 2019",2019-03-06 14:39:00-05:00,BPTH,positive
183027.0,Mid-Afternoon Market Update: Dow Down Over 100 Points; Bio-Path Shares Spike Higher,2019-03-06 14:38:00-05:00,BPTH,positive
183028.0,45 Stocks Moving In Wednesday's Mid-Day Session,2019-03-06 12:27:00-05:00,BPTH,neutral
183029.0,Bio-Path Shares Trading At Daily High Up 186% After Co Reported Phase 2 Trial Of Bp1001 For The Treatment Of Acute Myeloid Leukemia Demonstrated 'Meaningful Clinical Improvement' With An 'Excellent' Patient Safety Profile,2019-03-06 12:19:00-05:00,BPTH,positive
183030.0,Mid-Day Market Update: Abercrombie & Fitch Gains Following Upbeat Q4 Results; Valeritas Shares Slide,2019-03-06 12:00:00-05:00,BPTH,positive
183031.0,Mid-Morning Market Update: Markets Edge Lower; Dollar Tree Beats Q4 Views,2019-03-06 10:17:00-05:00,BPTH,negative
183032.0,Bio-Path shares are trading higher after the company's Phase 2 trial of BP1001 for the treatment of acute myeloid leukemia demonstrated 'meaningful clinical improvement' with an 'excellent' patient safety profile.,2019-03-06 08:05:00-05:00,BPTH,positive
183033.0,Bio-Path Offers Update To Interim Analysis Of Phase 2 Prexigebersen Trial In Acute Myeloid Leukemia: Showed 'Meaningful Clinical Improvement with Excellent Patient Safety Profile',2019-03-06 08:02:00-05:00,BPTH,positive
183034.0,71 Biggest Movers From Yesterday,2019-03-06 04:57:00-05:00,BPTH,neutral
183035.0,56 Stocks Moving In Tuesday's Mid-Day Session,2019-03-05 12:36:00-05:00,BPTH,neutral
183036.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning Of Tues., Mar. 5, 2019",2019-03-05 07:42:00-05:00,BPTH,positive
183037.0,62 Biggest Movers From Yesterday,2019-03-05 05:19:00-05:00,BPTH,neutral
183038.0,50 Stocks Moving In Monday's Mid-Day Session,2019-03-04 12:44:00-05:00,BPTH,neutral
183039.0,"Bio-Path Shares Resume Trade, Continue Lower, Now Down 15%",2019-03-04 10:14:00-05:00,BPTH,neutral
183040.0,"Bio-Path Shares Halted On Circuit Breaker, Down 10.9%",2019-03-04 10:05:00-05:00,BPTH,positive
183041.0,Bio-Path shares are trading lower in a potential sell off following Friday's 190% spike.,2019-03-04 09:10:00-05:00,BPTH,neutral
183042.0,"Benzinga Pro's Most-Searched Tickers For Morning Of Mon., Mar. 4, 2019",2019-03-04 08:47:00-05:00,BPTH,neutral
183043.0,30 Stocks Moving In Monday's Pre-Market Session,2019-03-04 08:02:00-05:00,BPTH,neutral
183044.0,81 Biggest Movers From Friday,2019-03-04 05:39:00-05:00,BPTH,neutral
183045.0,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Nutanix Shares Plunge On Weak Forecast,2019-03-01 14:31:00-05:00,BPTH,negative
183046.0,64 Stocks Moving In Friday's Mid-Day Session,2019-03-01 13:18:00-05:00,BPTH,neutral
183047.0,"Bio-Path Holdings shares are trading higher, now up nearly 100% after the company announced it will present data at the 2019 Association for Cancer Research annual meeting on April 30; the stock is trading on roughly 44 times average volume.",2019-03-01 10:25:00-05:00,BPTH,negative
183048.0,Bio-Path Holdings Early Thursday Announced It Will Present Data At 2019 AACR Annual Meeting,2019-03-01 10:19:00-05:00,BPTH,neutral
183049.0,75 Biggest Movers From Yesterday,2019-03-01 04:55:00-05:00,BPTH,neutral
183050.0,51 Stocks Moving In Thursday's Mid-Day Session,2019-01-24 12:43:00-05:00,BPTH,neutral
183051.0,52 Biggest Movers From Friday,2019-01-22 05:08:00-05:00,BPTH,neutral
183052.0,36 Stocks Moving In Friday's Mid-Day Session,2019-01-18 12:30:00-05:00,BPTH,neutral
183053.0,Mid-Day Market Update: Crude Oil Up 2.8%; Tyme Technologies Shares Plummet,2019-01-18 12:29:00-05:00,BPTH,negative
183054.0,Mid-Morning Market Update: Markets Open Higher; Tesla Cuts 7% Of Workforce,2019-01-18 10:13:00-05:00,BPTH,negative
183055.0,Bio-Path Holdings Announces 1-for-20 Reverse Stock Split,2019-01-18 08:02:00-05:00,BPTH,neutral
183056.0,"The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug",2019-01-18 07:49:00-05:00,BPTH,neutral
183057.0,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",2019-01-17 08:06:00-05:00,BPTH,positive
183058.0,"The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen",2019-01-16 08:24:00-05:00,BPTH,neutral
183059.0,55 Biggest Movers From Yesterday,2019-01-16 05:12:00-05:00,BPTH,neutral
183060.0,Mid-Afternoon Market Update: Dow Up 50 Points; First Republic Bank Shares Jump On Strong Q4 Results,2019-01-15 14:34:00-05:00,BPTH,positive
183061.0,Bio-Path Holdings shares are trading lower today after the company priced an 8.6M share offering at $0.13/share.,2019-01-15 12:38:00-05:00,BPTH,positive
183062.0,40 Stocks Moving In Tuesday's Mid-Day Session,2019-01-15 12:36:00-05:00,BPTH,neutral
183063.0,Mid-Day Market Update: Crude Oil Up 3%; Bio-Path Holdings Shares Plummet,2019-01-15 12:02:00-05:00,BPTH,negative
183064.0,Mid-Morning Market Update: Markets Rise; JPMorgan Earnings Miss Expectations,2019-01-15 10:15:00-05:00,BPTH,negative
183065.0,24 Stocks Moving In Tuesday's Pre-Market Session,2019-01-15 08:00:00-05:00,BPTH,neutral
183066.0,Bio-Path Holdings Prices 8.6M Share Public Offering of Common Stock @$0.13/Share,2019-01-15 03:31:00-05:00,BPTH,positive
183067.0,Bio-Path shares are trading down after the company announced a proposed stock offering.,2019-01-14 16:07:00-05:00,BPTH,positive
183068.0,"Bio-Path Holdings, Inc. Reports Proposed Common Stock Offering, No Size Disclosed",2019-01-14 16:01:00-05:00,BPTH,negative
183069.0,Bio-Path Holdings Provides Clinical Update And 2019 Business Outlook,2018-12-27 08:50:00-05:00,BPTH,neutral
183070.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,BPTH,neutral
183071.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,BPTH,neutral
183072.0,"The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",2018-12-13 07:56:00-05:00,BPTH,positive
183073.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 11, 2018",2018-12-12 11:47:00-05:00,BPTH,negative
183074.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",2018-12-06 07:56:00-05:00,BPTH,negative
183075.0,"The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings",2018-11-25 09:41:00-05:00,BPTH,neutral
183076.0,"Bio-Path Holdings, Inc. - Common Stock Q3 EPS $(0.27) Down From $(0.02) YoY",2018-11-15 07:07:00-05:00,BPTH,neutral
183077.0,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",2018-10-31 08:20:00-04:00,BPTH,negative
183078.0,"Stocks Which Set New 52-Week Low Yesterday, October 10th",2018-10-11 09:11:00-04:00,BPTH,negative
183079.0,"Stocks Which Set New 52-Week Low Friday, October 5th",2018-10-08 09:27:00-04:00,BPTH,negative
183080.0,"Stocks Which Set New 52-Week Low Yesterday, October 2nd",2018-10-03 13:01:00-04:00,BPTH,negative
183081.0,"Stocks Which Set New 52-Week Low Yesterday, October 1st",2018-10-02 09:24:00-04:00,BPTH,negative
183082.0,"Stocks Which Set New 52-Week Low Friday, September 21st",2018-09-24 09:48:00-04:00,BPTH,negative
183083.0,52 Biggest Movers From Friday,2018-09-24 06:22:00-04:00,BPTH,neutral
183084.0,Mid-Afternoon Market Update: Steelcase Surges On Earnings Beat; GTx Shares Slide,2018-09-21 14:31:00-04:00,BPTH,positive
183085.0,40 Stocks Moving In Friday's Mid-Day Session,2018-09-21 12:38:00-04:00,BPTH,neutral
183086.0,Mid-Day Market Update: Mazor Robotics Climbs Following Acquisition News; GTx Shares Plunge,2018-09-21 12:06:00-04:00,BPTH,positive
183087.0,Bio-Path Holdings shares are down 35.9% after the company reported the issuance and sale of 2.261M shares $0.65 per share.,2018-09-21 10:17:00-04:00,BPTH,positive
183088.0,Bio-Path Holdings Announces Issuance And Sale Of 2.261M Share Of Stock At $0.65/Share For Gross Proceeds Of ~$1.5M,2018-09-21 06:30:00-04:00,BPTH,negative
183089.0,"Stocks Which Set New 52-Week Low Yesterday, September 19th",2018-09-20 11:26:00-04:00,BPTH,negative
183090.0,"The Daily Biotech Pulse: Adverum Snags Fast Track Designation, Crispr To Offer Shares, Elanco Animal Health To Debut",2018-09-20 09:02:00-04:00,BPTH,positive
183091.0,"The Daily Biotech Pulse: Johnson & Johnson's Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering",2018-09-19 08:47:00-04:00,BPTH,negative
183092.0,"Stocks Which Set New 52-Week Low Yesterday, September 17th",2018-09-18 09:27:00-04:00,BPTH,negative
183093.0,"Stocks Which Set New 52-Week Low Yesterday, September 13th",2018-09-14 09:30:00-04:00,BPTH,negative
183094.0,"The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",2018-09-14 08:38:00-04:00,BPTH,neutral
183095.0,30 Stocks Moving In Monday's Mid-Day Session,2018-08-27 12:49:00-04:00,BPTH,neutral
183096.0,24 Stocks Moving In Monday's Pre-Market Session,2018-08-27 08:40:00-04:00,BPTH,neutral
183097.0,Bio-Path Holdings Reports First Patient Dosed In PHase 2 Trial Of Prexigebersen,2018-08-27 07:31:00-04:00,BPTH,neutral
183098.0,"The Daily Biotech Pulse: Vertex Awaits FDA Verdict, Strongbridge Falls On Offering, ReShape's Woes Continue",2018-08-15 08:48:00-04:00,BPTH,negative
183099.0,"Bio-Path Holdings, Inc. - Common Stock Q2 EPS $(0.15) Down From $(0.03) YoY",2018-08-15 07:04:00-04:00,BPTH,neutral
183100.0,"Earnings Scheduled For August 15, 2018",2018-08-15 03:51:00-04:00,BPTH,neutral
183101.0,"Benzinga's Daily Biotech Pulse: Gemphire On Fire, Acceleron-Celgene Taste Success, AbbVie Ditches Galapagos",2018-06-29 08:11:00-04:00,BPTH,positive
183102.0,"Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings",2018-05-16 08:10:00-04:00,BPTH,neutral
183103.0,"Bio-Path Holdings, Inc. - Common Stock Q1 EPS $(0.17)",2018-05-16 07:01:00-04:00,BPTH,neutral
183104.0,"Earnings Scheduled For May 16, 2018",2018-05-16 04:39:00-04:00,BPTH,neutral
183105.0,32 Biggest Movers From Yesterday,2018-04-20 05:42:00-04:00,BPTH,neutral
183106.0,Mid-Afternoon Market Update: Dow Slides 160 Points; Helios and Matheson Analytics Shares Plunge,2018-04-19 14:31:00-04:00,BPTH,positive
183107.0,30 Stocks Moving In Thursday's Mid-Day Session,2018-04-19 12:51:00-04:00,BPTH,neutral
183108.0,Mid-Day Market Update: Sears Hometown and Outlet Stores Falls Following Q4 Results; Bio-Path Shares Surge,2018-04-19 12:17:00-04:00,BPTH,positive
183109.0,27 Stocks Moving In Thursday's Pre-Market Session,2018-04-19 08:04:00-04:00,BPTH,neutral
183110.0,8 Stocks Moving In Wednesday's After-Hours Session,2018-04-18 17:45:00-04:00,BPTH,neutral
183111.0,Bio-Path Holdings Reports Pre-Clinical Data Demonstrating Potential Of Prexigebersen Presented at AACR,2018-04-18 16:15:00-04:00,BPTH,neutral
183112.0,36 Biggest Movers From Yesterday,2018-04-05 04:40:00-04:00,BPTH,neutral
183113.0,35 Biggest Movers From Yesterday,2018-04-04 04:20:00-04:00,BPTH,neutral
183114.0,Mid-Afternoon Market Update: Quest Resource Falls Following Q4 Results; Bio-Path Shares Surge,2018-04-03 14:33:00-04:00,BPTH,positive
183115.0,26 Stocks Moving In Tuesday's Mid-Day Session,2018-04-03 12:29:00-04:00,BPTH,neutral
183116.0,"Bio-Path Holdings Shares Up 31.3% After Phase 2 Clinical Trial Of Prexigebersen+LDAC For AML Showed Combo Was 'Well-Tolerated,' Showed 'Early Anti-Leukemic Activity' In 50% Of Evaluable Patients",2018-04-03 12:05:00-04:00,BPTH,positive
183117.0,Mid-Day Market Update: Dow Gains Over 200 Points; Enphase Energy Shares Plunge,2018-04-03 12:05:00-04:00,BPTH,positive
183118.0,Benzinga Pro's 5 Stocks To Watch Today,2018-04-03 08:35:00-04:00,BPTH,neutral
183119.0,"Bio-Path Holdings Says Phase 2 Clinical Trial Of Prexigebersen In Combination With Low Dose Cytarabine (LDAC) For Acute Myeloid Leukemia (AML) Showed Combination Was ""Well-Tolerated"" And Showed ""Early Anti-Leukemic Activity"" In 50% Of Evaluable Patients",2018-04-03 08:15:00-04:00,BPTH,negative
183120.0,17 Stocks Moving In Tuesday's Pre-Market Session,2018-04-03 08:02:00-04:00,BPTH,neutral
183121.0,Bio-Path Holdings Reports FY17 EPS $(0.80) vs $(0.73) In Prior Year Period,2018-04-03 07:38:00-04:00,BPTH,neutral
183122.0,"Earnings Scheduled For April 3, 2018",2018-04-03 04:05:00-04:00,BPTH,neutral
183123.0,"Bio-Path Reports 1-For-10 Reverse Split, Effective At Close Feb. 8",2018-02-09 07:00:00-05:00,BPTH,positive
183124.0,Bio-Path Reports Q3 EPS $(0.20) In-line With Est.,2017-11-09 16:25:00-05:00,BPTH,neutral
183125.0,"Bio-Path Offers Highlights Of Advancements In Preclinical Discovery Efforts: 'Selects New Drug Compound, BP1003, for Treatment of Pancreatic Cancer'",2017-11-06 08:11:00-05:00,BPTH,negative
183126.0,Bio-Path Receives Notice Of Listing Non-Compliance From Nasdaq,2017-08-16 16:10:00-04:00,BPTH,neutral
183127.0,Bio-Path Reports Q2 EPS $(0.03) vs $(0.02) Est.,2017-08-10 07:11:00-04:00,BPTH,neutral
183128.0,"Bio-Path Holdings Receives Notice of Allowance for Key U.S. Composition of Matter Patent, Further Protects Company's Proprietary Liposomal Delivery and Antisense Technology",2017-07-19 08:01:00-04:00,BPTH,positive
183129.0,"8-K From Bio-Path Shows Co. Sent Letter To Holders, Says Plans To Add New CFO With 'Significant Financial Experience To Ensure Bio-Path Is Building For The Future'",2017-06-20 09:08:00-04:00,BPTH,positive
183130.0,Bio-Path Holdings Reports Q1 EPS $(0.01) vs $(0.02) Est.,2017-05-11 07:06:00-04:00,BPTH,neutral
183131.0,Bio-Path Holdings Announces in vitro and in vivo Studies Supporting Potential Of BP1002 In NHL,2017-04-05 08:04:00-04:00,BPTH,positive
183132.0,Bio-Path Holdings Reports FY16 EPS $(0.07) vs. $(0.06) YoY,2017-03-15 07:01:00-04:00,BPTH,neutral
183133.0,S-3 from Bio-Path Shows Registration for $125M Mixed Securities Shelf Offering,2016-12-21 10:06:00-05:00,BPTH,positive
183134.0,Bio-Path Holdings Gives Update on BP1001,2016-12-06 07:04:00-05:00,BPTH,neutral
183135.0,Bio-Path Reports Q3 EPS $(0.02) vs $(0.01) Est.,2016-11-10 07:05:00-05:00,BPTH,neutral
183136.0,3 Stocks That Rallied Three Days On Increasing Volume,2016-11-07 07:37:00-05:00,BPTH,neutral
183137.0,Bio-Path Announces Orphan Drug Designation in the European Union for BP1001 for the Treatment of Acute Myeloid Leukemia,2016-11-03 08:00:00-04:00,BPTH,neutral
183138.0,Bio-Path Holdings Announces First Patient Dosed in Phase 2 Trial Evaluating BP1001 in Acute Myeloid Leukemia,2016-11-02 08:02:00-04:00,BPTH,neutral
183139.0,"Bio-Path Reports Q2 EPS $(0.02), Inline",2016-08-10 07:33:00-04:00,BPTH,neutral
183140.0,Bio-Path Holdings to Join Russell 3000,2016-06-20 16:02:00-04:00,BPTH,positive
183141.0,"Lightbridge Corporation (NASDAQ:LTBR), a U.S. nuclear energy company, today announced that it received a patent covering its metallic nuclear fuel rod design in Canada and has also received its patent in China following the notice of allowance announced",2016-06-06 09:01:00-04:00,BPTH,positive
183142.0,Bio-Path Reports Q1 EPS $(0.02) vs $(0.01) Est.,2016-05-11 07:32:00-04:00,BPTH,neutral
183143.0,"StreetSweeper Short Bio-Path: 'Unfortunate' Analyst Support, Little Executive Biotech Experience",2016-04-26 14:16:00-04:00,BPTH,positive
183144.0,StreetSweeper Issues Short Alert on BioPath,2016-04-26 12:35:00-04:00,BPTH,positive
183145.0,"Rodman & Renshaw Initiates Coverage on Bio-Path Holdings at Buy, Announces $5.00 PT",2016-04-18 07:06:00-04:00,BPTH,neutral
183146.0,Stocks Hitting 52-Week Highs,2016-04-05 10:07:00-04:00,BPTH,neutral
183147.0,Bio-Path Reports Research Collab on Autoimmune Indication with University of Texas Southwestern Medical Center,2016-03-23 08:55:00-04:00,BPTH,neutral
183148.0,Bio-Path Holdings Announces Pancreatic Cancer Research Collaboration with University Of Texas MD Anderson,2016-03-08 08:55:00-05:00,BPTH,negative
183149.0,Bio-Path Holdings' Data from Phase I and Safety Segment of Phase II Clinical Trials in Blood Cancers Presented At ASH Conf.,2015-12-08 08:55:00-05:00,BPTH,positive
183150.0,Bio-Path Reports Q3 EPS $(0.02) vs $(0.01) Est.,2015-11-10 08:55:00-05:00,BPTH,neutral
183151.0,Morning Market Gainers,2015-10-09 09:43:00-04:00,BPTH,neutral
183152.0,Bio-Path Holdings Announces Successful Completion of Cohort 7 of Phase Ib Clinical Trial Evaluating Liposomal Grb-2 in Acute Myeloid Leukemia,2015-10-09 08:55:00-04:00,BPTH,positive
183153.0,Bio-Path Holdings Forms Scientific Advisory Board to Support Advancement of Liposomal Grb-2 in Blood Cancers,2015-08-31 09:01:00-04:00,BPTH,positive
183154.0,Bio-Path Reports Q2 Loss of $0.01/Share vs Loss of $0.03/Share Est.,2015-08-11 09:04:00-04:00,BPTH,negative
183155.0,Bio-Path Holdings Shares Spike to High on Volume,2015-06-30 12:50:00-04:00,BPTH,positive
183156.0,"Bio-Path Holdings ""At-The-Market"" Offering With Cantor Fitzgerald",2015-06-25 12:28:00-04:00,BPTH,neutral
183157.0,UPDATE: Bio-Path Holdings Shares Rise 45% Following Tuesday's Orphan Drug Designation Announcement for Liposomal Grb-2 In Acute Myeloid Leukemia,2015-04-29 10:45:00-04:00,BPTH,positive
183158.0,Bio-Path Holdings Granted Orphan Drug Designation For Liposomal Grb-2 In Acute Myeloid Leukemia,2015-04-28 11:11:00-04:00,BPTH,positive
183159.0,Bio Path Holdings Says Would Like to Reiterate that We Believe the Fundamentals in Co Remain Strong and We are on Track with All of Our Programs,2015-04-24 12:12:00-04:00,BPTH,positive
183160.0,Bio-Path Reports Q4 EPS $(0.05) vs. Est. $(0.01),2015-03-17 08:31:00-04:00,BPTH,neutral
183161.0,Bio-Path Reports Commencement of Phase II STudy with Liposomal GRB-2 in AML Patients,2015-02-09 08:46:00-05:00,BPTH,positive
183162.0,Bio-Path Holdings Initiates Development Of Liposomal Bcl-2 in Follicular Lymphoma,2014-12-22 08:30:00-05:00,BPTH,neutral
183163.0,Bio-Path Holdings Reports Q3 Loss of $0.01/Share,2014-11-17 08:34:00-05:00,BPTH,negative
183164.0,Bio-Path Holdings Successfully Completes Cohort 6 of Phase I Clinical Trial Evaluating Liposomal Grb-2 in Blood Cancers ,2014-10-07 08:30:00-04:00,BPTH,positive
183165.0,Bio-Path Continues Phase I Enrollment,2014-06-19 08:33:00-04:00,BPTH,neutral
183166.0,Stocks Hitting 52-Week Lows,2014-04-01 10:30:00-04:00,BPTH,negative
183167.0,Stocks Hitting 52-Week Lows,2014-03-25 10:19:00-04:00,BPTH,negative
183168.0,Bio-Path (BPTH) Unique Drug Delivery Technology with Great Potential - Analyst Blog,2010-11-24 04:52:00-05:00,BPTH,positive
